Thu, Apr 24, 2014, 1:22 PM EDT - U.S. Markets close in 2 hrs 38 mins


% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

  • fezziwig2008 fezziwig2008 Feb 28, 2013 9:17 AM Flag

    Wait- Is This the Same Lpath That Summer Street Rated a Buy -Price Target $18- 2 Mos Ago?

    : Summer Street Initiates Lpath Incorporated at Buy on Valuation

    David Johnson, Benzinga Staff Writer
    December 27, 2012 11:11 AM


    Summer Street initiated coverage on Lpath Incorporated (NASDAQ: LPTN[FREE Stock Trend Analysis]) with a Buy rating and an $18 price target.

    Summer Street noted, "Lpath's valuation is compelling when compared to other platform companies in similar positions. Our iSONEP royalty projections begin in 2017 at $28MM and grow to $692MM in 2021, despite sharing the frontline market opportunity with a potential anti-PDGF inhibitor. By only including a portion of the frontline AMD market with VEGF inhibitors and the initial market refractory anti-VEGF agent failures, our model may be overly conservative." Lpath Incorporated closed at $4.90 on Wednesday.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.41-0.08(-1.76%)12:25 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.